BioSymetrics
BioSymetrics63
About
What does BioSymetrics do?
BioSymetrics is a phenomics-driven company that leverages AI and in vivo validation to translate complex human disease biology into discoveries. Their platform connects disease phenotype and genotype data, using machine learning predictions to identify higher-confidence targets and precision medicines.
What is BioSymetrics's revenue?
StartupHub estimates BioSymetrics's annual revenue at $4.5M (range $2.4M to $8.0M, 64% confidence), based on comparable companies in the sector.
What is BioSymetrics's valuation?
StartupHub estimates BioSymetrics's effective valuation at $26.3M (range $16.4M to $39.5M, 10% confidence), based on comparable companies in the sector.
How much funding has BioSymetrics raised?
BioSymetrics has raised a total of $7M in funding. The most recent round on record is Seed.
Where is BioSymetrics headquartered?
BioSymetrics is headquartered in Boston, United States.
When was BioSymetrics founded?
BioSymetrics was founded in 2017.
What industry does BioSymetrics operate in?
BioSymetrics operates in Biotech, HealthTech, Drug Discovery, Genomics, AI-Driven Drug Discovery, Precision Medicine.
How many employees does BioSymetrics have?
BioSymetrics has approximately 14 people on record.
No comments yet. Be the first to share your take.